We show here that ADAM9 functions as a key upstream regulator of Akt in CRC cells, possibly by cleaving class B ephrins, and that KD of ADAM9 differentially regulates downstream Wnt and mTOR signaling in CRC cell lines with different genetic mutations. This evidence concerns the gene ADAM9 and colorectal carcinoma.